| Característica |
Objectiu de la convocatòria
Funding for innovative projects in the field of non-alcoholic steatohepatitis (NASH).
|
Característiques principals
The ASPIRE NASH program will evaluate submitted research proposals that
cover areas in basic, clinical and translational sciences. The research
proposals with innovative and the potential of high impact in advancing the
learning about NASH will be encouraged.
The followings are the main areas of priority with high unmet needs:
Biopsy-confirmed NASH prevalence, clinical outcomes, and
healthcare utilization
Innovations in the use of non-invasive tools in the care of patients
with NASH
Understanding genetic drivers of NASH and identification of risk factors for disease progression in NASH
Real world evidence on current unmet need in patients with NASH and type 2 diabetes and/or obesity
Out of scope research includes:
Studies involving investigational products or medical devices including Pfizer’s
Pediatric studies
Dietary intervention studies
Stem cell therapy studies
Studies comparing a competitor drug vs. a Pfizer product
Highly invasive studies and studies that may have an ethical concern
Mere replication of existing studies (i.e., lack of innovation)
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: mlopez4@researchmar.net Ext.: 1576
Carol Barnwell: cbarnwell@researchmar.net Ext.1670
|
Convocatòria (URL)
https://cdn.pfizer.com/pfizercom/2023-09/2023-2024%20NASH%20ASPIRE%20RFP.pdf?VersionId=T5cE4vA4fRjg0UR81OfcIGNI_GGgmrs.
|
Requisits
Only organizations are eligible to receive grants, not individuals or
medical practice groups.
If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. All institutions must have a relevant role and the requesting organization must have a key role in the project.
The applicant (PI) must have a medical or postdoctoral degree (MD,
PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD),
or a degree in Pharmacy, Physiotherapy, or Social Work.
The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).
The PI must be an employee or independent contractor of the requesting organization.
Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
Both early career and experienced investigators are encouraged to apply
and consideration will be given to all proposals meeting the selection
criteria
|
Dotació
Up to $140,000
|
Durada
2-3 years.
|
Documentació
Proposals should be submitted at: www.cybergrants.com/pfizer/Research
|
AVÍS IMPORTANT
RFP Release Date: September 5, 2023
Full Proposal Due Date: January 4, 2024
|